Search
for
Sort by
Research 361–390 of 1000+
- Alopecia Areata
- Baricitinib for Alopecia Universalis Following Drug-Induced Hypersensitivity Syndrome/Drug Reaction with Eosinophilia and Systemic Symptoms
- Clinical evidence for JAK inhibition in alopecia areata: A comprehensive review
- Systemic Treatment of Moderate to Severe Alopecia Areata in Adults: Updated Australian Expert Consensus Statement
- Tofacitinib: The selected selective JAK inhibitor in paediatric dermatology
- Combination of baricitinib and conventional immunomodulating therapy for alopecia totalis
- Overview of alopecia areata for managed care and payer stakeholders in the United States
- Efficacy of Tofacitinib in the Treatment of Universal Alopecia Areata and Primary Sjögren Syndrome
- Treatment of moderate-to-severe alopecia areata in adolescents with baricitinib: A retrospective review of 29 patients
- Which is the ideal JAK inhibitor for alopecia areata – Baricitinib, tofacitinib, ritlecitinib or ifidancitinib - Revisiting the immunomechanisms of the JAK pathway
- Alopecia Areata: Current Review
- Alopecia Areata
- Treatment of alopecia areata with JAK inhibitors: a review of the literature
- Turning JAK STATic, a peek into the future of dermatology therapeutics
- Efficacy of Janus kinase inhibitors in adult patients with alopecia areata
- A phase 2a randomized, placebo-controlled study to evaluate the efficacy and safety of the oral Janus kinase inhibitors ritlecitinib and brepocitinib in alopecia areata: 24-week results
- Treatment of alopecia universalis with topical Janus kinase inhibitors – a double blind, placebo, and active controlled pilot study
- The Role of JAK Inhibitors in Atopic Dermatitis, Alopecia Areata, and Vitiligo: A Review article
- Studi Molecular Docking Aktivitas Anti Alopecia pada Senyawa yang Terkandung dalam Daun Dadap Serep (Erythrina subumbrans (Hassk.) Merrill)
- Alopecia areata
- JAK-inhibitors. New players in the field of immune-mediated diseases, beyond rheumatoid arthritis
- Alopecia areata
- Pharmacologic inhibition of JAK-STAT signaling promotes hair growth
- JAK inhibitors for alopecia areata: a systematic review and meta‐analysis
- Janus kinase inhibitors in dermatology: A systematic review
- The emerging role of Janus kinase inhibitors in the treatment of autoimmune and inflammatory diseases
- Topical Janus kinase inhibitors: A review of applications in dermatology
- WNT5A drives interleukin-6-dependent epithelial–mesenchymal transition via the JAK/STAT pathway in keloid pathogenesis
- Functional Interpretation of Genome-Wide Association Study Evidence in Alopecia Areata
- Inhibition of JAK-STAT Signaling with Baricitinib Reduces Inflammation and Improves Cellular Homeostasis in Progeria Cells